The U.S. Food and Drug Administration is investigating certain CAR T cancer therapies based on reports that they might cause a type of white blood cell to become cancerous in patients who received the treatment https://t.co/pEnAGKeNRX https://t.co/pEnAGKeNRX
— The Wall Street Journal (@WSJ) November 28, 2023
Ho boy
